Drug safety warnings may have unintended impact

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-020-75112-7
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:4 / 4
相关论文
共 50 条
  • [1] Do drug-related safety warnings have the expected impact on drug therapy? A systematic review
    Georgi, Ulrike
    Laemmel, Julia
    Datzmann, Thomas
    Schmitt, Jochen
    Deckert, Stefanie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (03) : 229 - 251
  • [2] Impact of regulatory safety warnings and restrictions on drug treatment of epilepsy
    Pong, Amanda W.
    Tyrlikova, Ivana
    Giermek, Alexander J.
    Klein, Pavel
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (02) : 111 - 114
  • [3] Effects of FDA Safety Warnings May Vary
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (09): : 894 - 895
  • [4] Examining the Impact of UK Drug Safety Warnings on Antipsychotic Drug Prescribing to Older People with Dementia
    Stocks, Susan J.
    Webb, Roger T.
    Kontopanatelis, Evangelos
    Burns, Alistair
    Ashcroft, Darren M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 262 - 263
  • [5] Impact of safety warnings on drug utilization: Marketplace life span of cisapride and troglitazone
    Wilkinson, JJ
    Force, RW
    Cady, PS
    PHARMACOTHERAPY, 2004, 24 (08): : 978 - 986
  • [6] Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark
    Hostenkamp, Gisela
    Fischer, Katharina Elisabeth
    Borch-Johnsen, Knut
    HEALTH POLICY, 2016, 120 (12) : 1404 - 1411
  • [7] THE IMPACT OF SAFETY WARNINGS ON PERCEPTION AND MEMORY
    URSIC, M
    HUMAN FACTORS, 1984, 26 (06) : 677 - 682
  • [8] Impact of the food and drug administration safety warnings and removal of indications for use of oral quinolones
    Tran, Phuong T.
    Antonelli, Patrick J.
    Hincapie-Castillo, Juan M.
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 151 - 152
  • [9] Determinants of Impact of Drug Safety Warnings: A Retrospective Analysis of Direct Healthcare Professional Communications
    Piening, Sigrid
    Reber, Katrin C.
    Wieringa, Jaap E.
    Straus, Sabine M.
    de Graeff, Pieter A.
    Haaijer-Ruskamp, Flora M.
    Mol, Peter G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 351 - 352
  • [10] Do Drug Warnings and Market Withdrawals Have an Impact on the Number of Calls to Teratogen Information Services?
    Sheehy, O.
    Gendron, M. -P.
    Martin, B.
    Berard, A.
    PHARMACOPSYCHIATRY, 2012, 45 (04) : 146 - 151